References
- Treede RD, Jensen TS, Campbell JN, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008;70:1630-5
- Dworkin RH, O’Connor AB, Backonja M, et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 2007;132:237-51
- Meier T, Wasner G, Faust M, et al. Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study. Pain 2003;106:151-8
- Repeat-Use Mutual Recognition Procedure: Lidocaine/Versatis 5% Medicated Plaster. 2011. Public Assessment Report. London: Medicines and Healthcare products Regulatory Agency (MHRA), 2011. Available at: www.mhra.gov.uk/home/groups/par/documents/websiteresources/con2032998.pdf [Last accessed 25 November 2013]
- Hans G, Joukes E, Verhulst J, et al. Management of neuropathic pain after surgical and non-surgical trauma with lidocaine 5% patches: study of 40 consecutive cases. Curr Med Res Opin 2009;25:2737-43
- Gammaitoni AR, Galer BS, Onawola R, et al. Lidocaine patch 5% and its positive impact on pain qualities in osteoarthritis: results of a pilot 2-week, open-label study using the Neuropathic Pain Scale. Curr Med Res Opin 2004;20(Suppl 2):S13-19
- Gimbel J, Linn R, Hale M, et al. Lidocaine patch treatment in patients with low back pain: results of an open-label, nonrandomized pilot study. Am J Ther 2005;12:311-19
- Herrmann DN, Barbano RL, Hart-Gouleau S, et al. An open-label study of the lidocaine patch 5% in painful idiopathic sensory polyneuropathy. Pain Med 2005;6:379-84
- Mick G, Correa-Illanes G. Topical pain management with the 5% lidocaine medicated plaster – a review. Curr Med Res Opin 2012;28:937-51
- Neuropathic Pain. London: The Map of Medicine and the British Pain Society, 2013. Available at: bps.mapofmedicine.com/evidence/bps/neuropathic_pain1.html [Last accessed 25 November 2013]
- Becker N, Bondegaard Thomsen A, Olsen AK, et al. Pain epidemiology and health related quality of life in chronic non-malignant pain patients referred to a Danish multidisciplinary pain center. Pain 1997;73:393-400
- Langley PC, Liedgens H. The impact of pain severity and frequency on HRQoL in the big 5 European Union countries. Value Health 2010;13:A395
- Dixon S, Poole CD, Odeyemi I, et al. Deriving health state utilities for the numerical pain rating scale. Health Qual Life Outcomes 2011;9:96
- Galer BS, Gammaitoni AR, Oleka N, et al. Use of the lidocaine patch 5% in reducing intensity of various pain qualities reported by patients with low-back pain. Curr Med Res Opin 2004;20(Suppl 2):S5-12